Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients

Annamaria Ruzzo, Mauro Magnani, Fabio Galli et al.|British Journal of Cancer|2017

Cited by 68